|
|
|
|
||
Re: Sotyktu/Deucra Abstract Titles at ACR2022 10-14Nov2022 makes sense and I think the sales force will be able to differentiate on the starting dose alone: deucra is so well tolerated that you can start with the maintenance dose as dose one whereas apr takes at least a week to be titrated up given it's GI intolerance. |
return to message board, top of board |